📝Personal View Multidimensional prognostic risk stratification of #COPD exacerbations: the baseline, acuity, and trigger (BAt) model www.thelancet.com/journals/lan... Also check out the associate podcast: www.buzzsprout.com/admin/145996...

❇️ Series hub page now live – Prematurity-associated Lung Disease www.thelancet.com/series-do/pr... The hub includes links to the three Series papers, a Comment, and profile as well as our latest podcast to accompany the Series 🎧 www.buzzsprout.com/1459960/epis...

📰 News Cough syrup contamination in India, written by Cahal McQuillan Read more on this horrifying tragedy resulting in the deaths of at least 25 children to date due to contaminated cough syrup. www.thelancet.com/journals/lan...

🗞️ Weekly news round up! 🔹 GOLD #COPD report: 2026 update written by Priya Venkatesan www.thelancet.com/journals/lan... Check out our round up of the major updates in this year's Global Initiative for Chronic Obstructive Lung Disease #GOLD strategy report.

🫁 Two promising #LungCancer papers published in this week! ❇️ First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, phase 3 trial tinyurl.com/3zd7dcuj

Monthly injection may help severe asthma patients safely reduce or stop daily oral steroid use, suggests new study in @lancetrespirmed.bsky.social Explore the research 👉 spkl.io/63328Ae4di

🗓️ New Series – Prematurity-associated Lung Disease The Series was launched today at the @btsrespiratory.bsky.social Winter Meeting 🔹Preterm birth is increasingly recognised as a determinant of chronic respiratory disease in childhood and adulthood

▶️ Important new phase 3 trial published today and presented at the @btsrespiratory.bsky.social Winter Meeting 📑 Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled #asthma treated with tezepelumab (WAYFINDER) 🔓 tinyurl.com/444ptsz4

❄️ The Lancet Respiratory Medicine’s December issue is out now! This issue features a bumper crop of content on non-small-cell #LungCancer, #CysticFibrosis, mechanical ventilation, and much more! Check out the full issue here: www.thelancet.com/issue/S2213-... #respmed #lungsky

We had an amasing time in Copenhagen at the World Conference on Lung Health - The Union 2025 #UNIONCONF Thank to all the participants for the great interactions and to the organisers for inviting us!

🌍 Today is #WorldCOPDDay We would like to highlight a paper in our recent Series on the Global Epidemiology of Chronic Respiratory Disease, looking at epidemiology and effect of prevention strategies on #COPD burden globally 🔗 www.thelancet.com/journals/lan...

👇 New Editorial in @lancetrespirmed.bsky.social "Public trust: the vaccine against vaccine hesitancy" spkl.io/63329AjIAl

📰 News: #RSV in 2025–26: immunisation gaps and opportunities Written by Cahal McQuillan ⛓️‍💥 www.thelancet.com/journals/lan... For the Lancet-Lancet Respiratory Medicine Series on RSV see www.thelancet.com/series-do/re...

What if we could shape the future of oncology publishing to better serve patients? Join Vania Wisdom on Nov 27 to explore how we can find a better path forward for liver cancer care 👉 Register: hubs.li/Q03GK-q50

📑 Explore our 40th #EACTAIC Annual Congress 2025 content Effects of intraoperative higher versus lower PEEP during one-lung ventilation for thoracic surgery on postoperative pulmonary complications (PROTHOR): a multicentre, international, phase 3 RCT ⛓️‍💥 www.thelancet.com/journals/lan...

@uhn.ca, @uoftmedicine.bsky.social, @lancetrespirmed.bsky.social

📜 New Editorial Public trust: the #vaccine against vaccine hesitancy To overcome doubts and hesitancy, a single message—impartial and accessible, guided by science, and grounded in validated data—needs to be heard. tinyurl.com/mr2uehcp @gavi.org @who.int

🌏 Despite substantial progress, asthma still poses a serious health burden globally. A Lancet—@lancetrespirmed.bsky.social Series provides new insights into the genetics, prevention, & risk factors of the disease: spkl.io/63322Abjbm

Ahead of The Union World Conference on Lung Health, Katherine Horton provides @the-independent.com with insights into the devastating impact of the funding cuts on global health, particularly tuberculosis. Be sure to read about the threat of UK aid cuts: www.independent.co.uk/news/uk/poli...

📰 New Position Paper A paradigm shift in corticosteroid therapy for #sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders www.thelancet.com/journals/lan...

The 2025 @lancetcountdown.bsky.social report reveals climate change inaction is costing lives and livelihoods, and harming the economy. During #COP30, explore recommendations for action: spkl.io/63324AbjGM#COP30#LancetClimate25

📰 News US lung cancer report suggests years of encouraging progress under threat from health agency cuts Written by Tony Kirby www.thelancet.com/journals/lan...

🌍 Climate change and #tuberculosis 🔹 Commissioned by @whowpro.bsky.social, the authors developed an analytical framework outlining potential causal relationships between climate change and TB, highlighting the need to consider TB as a climate-sensitive disease 🖇️ tinyurl.com/4ccn5kad

Our framework that informed the @who.int TB & climate change policy brief out now in @lancetrespirmed.bsky.social, exploring the intersections and implications of climate change for the TB epidemic. Key message? TB should be considered a climate-sensitive disease www.thelancet.com/journals/lan...

🍂 🍁 The Lancet Respiratory Medicine’s November issue is out now! 📜 This issue includes groundbreaking work on IPF, asthma, and breathlessness, among many other #respmed and #criticalcare topics Check out the full issue here: www.thelancet.com/journals/lan...

🌟 Fantastic to see this Article named as the RCGP Research Paper of the Year! Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled trial ⛓️‍💥 Read the full paper here: www.thelancet.com/journals/lan...

🚨 New Editorial Redefining outcomes in #asthma —remission and beyond "Even though a cure for asthma is at this point aspirational, having cure as a target is the first step to achieving this goal" www.thelancet.com/journals/lan...

📰 New cohort study: Association of medication-induced deep sedation and emotional distress during mechanical ventilation with loss of independent living Lighter sedation was associated with lower risk of loss of independent living www.thelancet.com/journals/lan...

🗞️ News: European Respiratory Society International Congress 2025 This round up features exciting breakthroughs and updates on trials in #COPD, #PAH, #IPF and #bronchiectasis The 2025 ERS Congress was held in Amsterdam, Netherlands from Sept 27–Oct 1, 2025 ⛓️‍💥 Read in full here: tinyurl.com/3r6zepfd

🔔 Introducing The Lancet Regional Health – Africa, a new #goldopenaccess journal promoting the advancement of clinical practice and health policy in Africa. Explore the new journal at hubs.li/Q03KzMp00 #MedSky

ICYMI: Our new cross-journal Series with @thelancet.com on #Asthma is now live: www.thelancet.com/series-do/as...

🫁 Explore our October 2025 issue, out now in print and online! This issue covers a multitude of respiratory and critical care content including mechanical ventilation, #NSCLC, #bronchiectasis, as well as out-of-hospital cardiac arrest. www.thelancet.com/issue/S2213-... #respmed #lungsky

300 million people have asthma. A joy co-authoring this @lancetrespirmed.bsky.social MS: Genetic+ environmental risk factors for asthma: towards prevention, led by G Koppelman+G Bruselle with @erikmelen.bsky.social+ M Pino as co-authors @atscommunity.bsky.social authors.elsevier.com/c/1ls9A7tFB1...

🫁 Asthma 2025 🫁 New Series on #Asthma, launched today at #ERSCongress Check out the Series hub here: www.thelancet.com/series-do/as... 👩‍⚕️ In this Series, we provide new insights into the genetics, prevention, and risk factors of the disease; monoclonal antibody therapeutics; and remission

⏰#ERSCongress ALERT 📰 #Morphine for chronic #breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, RCT This study found no evidence that morphine improves worst breathlessness intensity Online now and free to access: www.thelancet.com/journals/lan...

King’s researchers Irene Higginson & @sbajwah.bsky.social contributed to the MABEL trial, published today in @lancetrespirmed.bsky.social, examining the role of morphine in chronic breathlessness. 🔗 www.thelancet.com/journals/lan...

⏰#ERSCongress ALERT 📰 Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial 🔓 Online now and free to access for all: tinyurl.com/4nhbtj89

🌍 New @lancetrespirmed.bsky.social! Pooled sputum testing for TB: revisiting a cost-saving innovation 🚫 Let's bust pooling myths & misconceptions! 🔬 Pooling is efficient, accurate, cost-saving & improves equity of access! 📖 Read at doi.org/10.1016/S221... Thanks @unitaid.bsky.social for funding!

💡New Spotlight: Chronic respiratory diseases and inhalers in Africa Esther Nakkazi reports on chronic respiratory diseases as a neglected health crisis ahead of the 4th High-level Meeting of the UN General Assembly in New York on Sept 25, 2025 tinyurl.com/yejfbz2v

🌉 Only a few days now until #ERSCongress in Amsterdam! 📰 We will be launching our new cross-journal Series with @thelancet.com on #asthma on 30th September at 10:15 CEST 📅The Lancet Group will be publishing plenty of new respiratory content during the conference so keep an eye out for updates!

📈 New phase 3 trial in #lungcancer Retifanlimab vs placebo with platinum-based chemotherapy in patients with first-line metastatic non-small-cell lung cancer (POD1UM-304) Retifanlimab improved overall survival compared with placebo when added to platinum-based chemotherapy tinyurl.com/483jf7k8

📚 New Editorial Farming life: a double-edged sword for respiratory health The #farming environment is an exemplar of disparate and antagonistic influences on respiratory health www.thelancet.com/journals/lan...

💡Spotlight Chrysotile asbestos—the deadly consequences of a retreat from national bans "There is no safe level of asbestos, whether chrysotile or amphibole, and global bans remain the only solution to this ongoing devastating occupational health tragedy" tinyurl.com/5n7rctz2

📰The Lancet Respiratory Medicine’s September issue is out now Read content on obstructive sleep apnoea, #tuberculosis, cardiogenic shock, #pneumonia, and much more Check out the full issue here: bit.ly/3P2PVls

🗞️ News Vaccine disinformation motivated gunman's attack on US CDC headquarters @bryantfurlow.bsky.social tinyurl.com/mu2nen8d

Abrupt funding cuts to international aid are disrupting essential tuberculosis (TB) services. Ending TB remains within reach—but only with adequate adaptation, investment, and will. New Comment ⤵️ tinyurl.com/2xccptr5

🌎 Symposium Spotlight Join us at the Union World conference on Lung Health for a critical symposium with The Lancet Global Health Commission on Medical Oxygen Security. 🗓️18 November 2025 ⏰ 11:30 - 13:00

📰 The US FDA has approved the first immunotherapy for recurrent respiratory papillomatosis tinyurl.com/3db69ye4 Approval is based on a pivotal phase 1/2 clinical trial of PRGN-2012 gene therapy published in @lancetrespirmed.bsky.social 🔗 Check out the full trial results here: tinyurl.com/yzjdc665

💡New Spotlight Unique perspective on cystic fibrosis at @edfringe.bsky.social by Peter Ranscombe tinyurl.com/5r8sykbn